Earnings: October 2021

Loading...
Symbol Company Time EPS
Symbol Company Time EPS
Symbol Company Time EPS
N/A

A

Agilent Technologies, Inc


--

--(%) As of: -- EDT

$--

Open

$--

Prev Close
Fundamentals
52 Wk Height
52 Wk Low
PE Ratio
Exchange: NYSE
Analyst Ratings
Strong Buy 10
Buy 0
Hold 2
Sell 0
Strong Sell 0
Stock Price Target
High $200.00
Low $158.00
Average $175.41
No. of Analysts: 17
Expected EPS

$0.00

Join Webcast
Company URL http://www.agilent.com
Call Date -
Call Time EST
Call Pass Code ---
Call Phone No. ---
Amount

$0.78

Yields

0%

Company URL http://www.agilent.com
Declaration Date May-19-2021
Ex-Dividend Date July-02-2021
Record Date July-06-2021
Pay Date July-28-2021

Company Description:

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.

Sector:

Healthcare

Industry:

Diagnostics & Research

Social Sentiment

  • 0% Bullish
  • 0% Bearish

StockPods Mobile

Mobile Device Detected

Stockpods mobile app is on the way. Bringing the functionality of Stockpods.com to your fingertips.

For now, please enjoy our offering on a desktop or laptop.

Subscribe for the latest updated, news and features.

contact@stockpods.com

Kirkland, WA USA